Infinium Global Research Methicillin-Resistant Staphylococcus Aureus Drugs | Page 2

A latest report has been added to the wide database of Methicillin-Resistant Staphylococcus Aureus Drugs Market by Infinium Global
Research. This report studies the Methicillin-Resistant Staphylococcus Aureus Drugs Market by drug class (cephalosporin, lipopeptides,
lipoglycopeptide, folate antagonist, tetracycline, and oxazolidinone), MOA (bactericidal drugs, bacteriostatic), drug origin (synthetic
drugs, semisynthetic) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of
the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years.
Methicillin-Resistant Staphylococcus Aureus Drugs Market provides opportunities in micro markets for stakeholders to invest along
with the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the Methicillin-
Resistant Staphylococcus Aureus Drugs Market. According to report the global methicillin-resistant staphylococcus aureus drugs
market is projected to grow at a CAGR of 2.5% over the forecast period of 2018-2024.
Segment Covered
The report on global methicillin-resistant staphylococcus aureus drugs market covers segments such as, drug class, MOA and drug
origin. On the basis of drug class the global methicillin-resistant staphylococcus aureus drugs market is categorized into cephalosporin,
lipopeptides, lipoglycopeptide, folate antagonist, tetracycline and oxazolidinone. On the basis of MOA the global methicillin-resistant
staphylococcus aureus drugs market is categorized into bactericidal drugs and bacteriostatic. On the basis of drug origin the global
methicillin-resistant staphylococcus aureus drugs market is categorized into synthetic drugs and semisynthetic.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this
section the key trends and market size for each geography is provided over the period of 2016-2024. The countries covered in the
North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the
growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the
market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a
CAGR of x.x% over the period of 2018-2024.